--- title: "LIFEMD 截止日期提醒:Bragar Eagel & Squire, P.C. 敦促 LifeMD 的投資者在 10 月 27 日截止日期前與該公司聯繫" description: "Bragar Eagel & Squire, P.C. 的訴訟合夥人 Brandon Walker 鼓勵在 LifeMD (LFMD) 中遭受損失的投資者直接聯繫他,以討論他們的選擇" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/261106029.md" published_at: "2025-10-14T15:38:03.000Z" --- # LIFEMD 截止日期提醒:Bragar Eagel & Squire, P.C. 敦促 LifeMD 的投資者在 10 月 27 日截止日期前與該公司聯繫 > Bragar Eagel & Squire, P.C. 的訴訟合夥人 Brandon Walker 鼓勵在 LifeMD (LFMD) 中遭受損失的投資者直接聯繫他,以討論他們的選擇 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD ( LFMD ) To Contact Him Directly To Discuss Their Options ### Related Stocks - [LFMD.US - LifeMD](https://longbridge.com/zh-HK/quote/LFMD.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | LifeMD Secures $50 Million Revolving Credit Facility from Citizens Bank | LifeMD Inc. has secured a $50 million revolving credit facility from Citizens Bank, which includes $30 million in commit | [Link](https://longbridge.com/zh-HK/news/271657692.md) | | Lake Street Keeps Their Buy Rating on LifeMD (LFMD) | Lake Street's Ryan Meyers maintains a Buy rating on LifeMD with a price target of $8.00. The analyst, covering the Consu | [Link](https://longbridge.com/zh-HK/news/270855288.md) | | LifeMD Chief Marketing Officer Jessica Friedeman Reports Sale of Common Shares | Jessica Friedeman, Chief Marketing Officer of LifeMD Inc., has reported the sale of common shares of the company. This i | [Link](https://longbridge.com/zh-HK/news/269437200.md) | | LifeMD Delays Quarterly Financial Report Over Revenue Recognition Errors | LifeMD Inc. has delayed its Quarterly Report on Form 10-Q for the period ended September 30, 2025, due to the need for a | [Link](https://longbridge.com/zh-HK/news/265596760.md) | | LifeMD (NASDAQ:LFMD) Releases Earnings Results, Misses Expectations By $0.04 EPS | LifeMD reported a quarterly EPS of ($0.10), missing the consensus estimate of ($0.06) by $0.04. The stock rose 2.2% to $ | [Link](https://longbridge.com/zh-HK/news/266438689.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。